日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study

剖析重度抑郁症皮质厚度异常的异质性:一项大规模 ENIGMA MDD 常模模型研究

Bayer, J M M; van Velzen, L S; Pozzi, E; Davey, C; Han, L K M; Bauduin, S E E C; Bauer, J; Benedetti, F; Berger, K; Bonnekoh, L M; Brosch, K; Bülow, R; Couvy-Duchesne, B; Cullen, K R; Dannlowski, U; Dima, D; Dohm, K; Evans, J W; Fu, C H Y; Fuentes-Claramonte, P; Godlewska, B R; Goltermann, J; Gonul, A; Goya-Maldonado, R; Grabe, H J; Groenewold, N A; Grotegerd, D; Gruber, O; Hahn, T; Hall, G B; Hamilton, J; Harrison, B J; Hatton, S N; Hermesdorf, M; Hickie, I B; Ho, T C; Jahanshad, N; Jansen, A; Jamieson, A J; Kamishikiryo, T; Kircher, T; Klimes-Dougan, B; Krämer, B; Kraus, A; Krug, A; Leehr, E J; Leenings, R; Li, M; McIntosh, A; Medland, S E; Meinert, S; Melloni, E; Mwangi, B; Nenadić, I; Okada, G; Oudega, M; Portella, M J; Rodríguez, E; Romaniuk, L; Rosa, P G; Sacchet, M D; Salvador, R; Sämann, P G; Shinzato, H; Sim, K; Simulionyte, E; Soares, J C; Stein, D J; Stein, F; Stolicyn, A; Straube, B; Strike, L T; Teutenberg, L; Thomas-Odenthal, F; Thomopoulos, S I; Usemann, P; van der Wee, N J A; Völzke, H; Wagenmakers, M; Walter, M; Whalley, H C; Whittle, S; Winter, N R; Wittfeld, K; Wu, M; Yang, T T; Zarate, C A; Zunta-Soares, G B; Thompson, P M; Veltman, D J; Marquand, A F; Schmaal, L

The effects of ketamine on typical and atypical depressive symptoms

氯胺酮对典型和非典型抑郁症状的影响

Park, L T; Luckenbaugh, D A; Pennybaker, S J; Hopkins, M A; Henter, I D; Lener, M S; Kadriu, B; Ballard, E D; Zarate, C A Jr

Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.

急性氯胺酮给药可纠正重度抑郁症患者的异常炎症性骨标志物

Kadriu B, Gold P W, Luckenbaugh D A, Lener M S, Ballard E D, Niciu M J, Henter I D, Park L T, De Sousa R T, Yuan P, Machado-Vieira R, Zarate C A

cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor

未接受药物治疗的抑郁症患者大脑中的 cAMP 信号传导减弱,而使用选择性血清素再摄取抑制剂治疗后,该信号传导增强。

Fujita, M; Richards, E M; Niciu, M J; Ionescu, D F; Zoghbi, S S; Hong, J; Telu, S; Hines, C S; Pike, V W; Zarate, C A; Innis, R B

Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders

氯胺酮:将机制发现转化为用于治疗情绪障碍的新一代谷氨酸调节剂

Zarate, C A Jr; Machado-Vieira, R

The role of adipokines in the rapid antidepressant effects of ketamine.

脂肪因子在氯胺酮快速抗抑郁作用中的作用

Machado-Vieira R, Gold P W, Luckenbaugh D A, Ballard E D, Richards E M, Henter I D, De Sousa R T, Niciu M J, Yuan P, Zarate C A Jr

Animal models to improve our understanding and treatment of suicidal behavior

利用动物模型增进我们对自杀行为的理解和治疗

Gould, T D; Georgiou, P; Brenner, L A; Brundin, L; Can, A; Courtet, P; Donaldson, Z R; Dwivedi, Y; Guillaume, S; Gottesman, I I; Kanekar, S; Lowry, C A; Renshaw, P F; Rujescu, D; Smith, E G; Turecki, G; Zanos, P; Zarate, C A Jr; Zunszain, P A; Postolache, T T

Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories

单剂量输注氯胺酮和非氯胺酮类N-甲基-D-天冬氨酸受体拮抗剂治疗单相和双相抑郁症:疗效、安全性和时间轨迹的荟萃分析

Kishimoto, T; Chawla, J M; Hagi, K; Zarate, C A; Kane, J M; Bauer, M; Correll, C U

Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

初步证据表明,自然杀伤细胞和单核细胞中 p11 水平的早期降低可预测长期服用西酞普兰后出现抗抑郁反应的可能性。

Svenningsson, P; Berg, L; Matthews, D; Ionescu, D F; Richards, E M; Niciu, M J; Malinger, A; Toups, M; Manji, H; Trivedi, M H; Zarate, C A Jr; Greengard, P

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

氯胺酮的抗快感缺失作用及其在难治性双相抑郁症中的神经关联

Lally, N; Nugent, A C; Luckenbaugh, D A; Ameli, R; Roiser, J P; Zarate, C A